Literature DB >> 25494458

Fanconi syndrome induced by vemurafenib: a new renal adverse event.

Daphné Denis1, Nathalie Franck1, Fanny Fichel1, Charlène Levi2, Nicolas Dupin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25494458     DOI: 10.1001/jamadermatol.2014.4529

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

1.  Nonconvulsive Status Epilepticus in Elderly Patients Receiving SSRIs; Euglycemic Diabetic Ketoacidosis Associated with Canagliflozin Use in a Type 1 Diabetic Patient; Duloxetine-Induced Galactorrhea; Canagliflozin-Associated Severe Hypercalcemia and Hypernatremia; Vemurafenib-Induced Fanconi Syndrome.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2015-10-14

Review 2.  Renal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International Network.

Authors:  Rimda Wanchoo; Kenar D Jhaveri; Gilbert Deray; Vincent Launay-Vacher
Journal:  Clin Kidney J       Date:  2016-01-18

Review 3.  Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review.

Authors:  Kenar D Jhaveri; Rimda Wanchoo; Vipulbhai Sakhiya; Daniel W Ross; Steven Fishbane
Journal:  Kidney Int Rep       Date:  2016-09-21

Review 4.  Novel Drugs and Combination Therapies for the Treatment of Metastatic Melanoma.

Authors:  Adarsh Vennepureddy; Nishitha Thumallapally; Vijeyaluxmy Motilal Nehru; Jean-Paul Atallah; Terenig Terjanian
Journal:  J Clin Med Res       Date:  2015-12-28

5.  Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma.

Authors:  Charlotte Hurabielle; Evangéline Pillebout; Thomas Stehlé; Cécile Pagès; Jennifer Roux; Pierre Schneider; Sylvie Chevret; Cendrine Chaffaut; Anne Boutten; Samia Mourah; Nicole Basset-Seguin; Emmanuelle Vidal-Petiot; Céleste Lebbé; Martin Flamant
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.